Tirzepatide Once Weekly for the Treatment of Obesity AMG 133 is a novel bispecific glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist and glucagon-like peptide-1 (GLP-1) receptor agonist molecule
The company has a notable footprint in the GLP-1 agonists market through innovative products that are used for blood glucose control, plus weight management therapies
Eat apples, celery, veggies, and other good-for-you forms of fiber
In the United States, the Centers for Disease Control and Prevention (CDC) reports that over 38.4 million individuals, approximately 11.6% of the population, are currently living with diabetes [2]
The Journal ofclinical investigation, 127(12), 42174227
Weill Professor of Metabolic Research at Weill Cornell